Cell News and Research

RSS
U-M researchers reveal key gene that may provide potential target for cancer treatment

U-M researchers reveal key gene that may provide potential target for cancer treatment

Gamida Cell granted FDA and EMA orphan drug designation for NiCord

Gamida Cell granted FDA and EMA orphan drug designation for NiCord

EnGeneIC closes oversubscribed Series B financing

EnGeneIC closes oversubscribed Series B financing

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for treatment of GBM

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for treatment of GBM

Johns Hopkins scientists use genome editing technology to alter human stem cells

Johns Hopkins scientists use genome editing technology to alter human stem cells

BrainStorm's phase 2a ALS study meets primary endpoint

BrainStorm's phase 2a ALS study meets primary endpoint

New findings may lay groundwork of novel treatment for people with Huntington's disease

New findings may lay groundwork of novel treatment for people with Huntington's disease

Elsevier launches new virtual journal: Atlas

Elsevier launches new virtual journal: Atlas

Study: Placental cells may possibly treat damaged nerves

Study: Placental cells may possibly treat damaged nerves

TxCell announces further enhancement to development of Ovasave for IBD treatment

TxCell announces further enhancement to development of Ovasave for IBD treatment

Luck is a key factor in cancer development

Luck is a key factor in cancer development

Fat cells below skin help protect from bacteria, say researchers

Fat cells below skin help protect from bacteria, say researchers

Johns Hopkins scientists create statistical model to measure proportion of cancer incidence

Johns Hopkins scientists create statistical model to measure proportion of cancer incidence

UT Southwestern researchers target cells' biological clock to kill cancer cells, shrink tumor growth

UT Southwestern researchers target cells' biological clock to kill cancer cells, shrink tumor growth

New treatment approach may improve survival rates for certain patients with stage 4 lung cancer

New treatment approach may improve survival rates for certain patients with stage 4 lung cancer

Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research

Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research

Study shows that reprogramming stem cells can prevent cancer following full body radiation

Study shows that reprogramming stem cells can prevent cancer following full body radiation

OncoGenex executes initial agreement with Teva to regain rights to custirsen

OncoGenex executes initial agreement with Teva to regain rights to custirsen

LIBD announces significant advances in identifying causes of schizophrenia, brain disorders

LIBD announces significant advances in identifying causes of schizophrenia, brain disorders

Anthera Pharmaceuticals to host Lupus symposium in San Francisco

Anthera Pharmaceuticals to host Lupus symposium in San Francisco

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.